Thirteen novel aryloxy cyclohexane-based mono and bis imidazoles have been synthesized and evaluated in vitro as antileishmanials in opposition to Leishmania donovani and cytotoxicity assessed. These compounds have been higher than the prevailing medicine, sodium stibogluconate and pentamidine in respect to IC and SI values. Among all, the bis methylimidazole
